Matches in Nanopublications for { ?s ?p "[These data support a role of E2F-1 as tumour suppressor gene in lymphoma and strongly suggest that the RB1 and p53 pathways are important in the development of de novo DLCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP576236.RAZ3VgsDMl0KibefJ-PoJGp3tHGHwxDsJ-BzIFOV4I2wI130_assertion description "[These data support a role of E2F-1 as tumour suppressor gene in lymphoma and strongly suggest that the RB1 and p53 pathways are important in the development of de novo DLCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576236.RAZ3VgsDMl0KibefJ-PoJGp3tHGHwxDsJ-BzIFOV4I2wI130_provenance.
- NP759246.RAVUi6xdke6yVn9wkEb0lMCXjgbKs1stKOyF3oR7qLsdI130_assertion description "[These data support a role of E2F-1 as tumour suppressor gene in lymphoma and strongly suggest that the RB1 and p53 pathways are important in the development of de novo DLCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759246.RAVUi6xdke6yVn9wkEb0lMCXjgbKs1stKOyF3oR7qLsdI130_provenance.
- NP494735.RAPRVegP5_6Q-rQIitHmlX1-eOOfFAqaXuPC9SlyimocU130_assertion description "[These data support a role of E2F-1 as tumour suppressor gene in lymphoma and strongly suggest that the RB1 and p53 pathways are important in the development of de novo DLCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494735.RAPRVegP5_6Q-rQIitHmlX1-eOOfFAqaXuPC9SlyimocU130_provenance.
- NP632724.RAMV3pdzNEiWgZKJYBtaMw5BaWCuq8NrSxmqEUA9tKc_c130_assertion description "[These data support a role of E2F-1 as tumour suppressor gene in lymphoma and strongly suggest that the RB1 and p53 pathways are important in the development of de novo DLCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632724.RAMV3pdzNEiWgZKJYBtaMw5BaWCuq8NrSxmqEUA9tKc_c130_provenance.
- assertion description "[These data support a role of E2F-1 as tumour suppressor gene in lymphoma and strongly suggest that the RB1 and p53 pathways are important in the development of de novo DLCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These data support a role of E2F-1 as tumour suppressor gene in lymphoma and strongly suggest that the RB1 and p53 pathways are important in the development of de novo DLCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These data support a role of E2F-1 as tumour suppressor gene in lymphoma and strongly suggest that the RB1 and p53 pathways are important in the development of de novo DLCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These data support a role of E2F-1 as tumour suppressor gene in lymphoma and strongly suggest that the RB1 and p53 pathways are important in the development of de novo DLCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP283301.RACm1-PxFfDdy1NHmFA-kI52NMIkY0F_VtfZqudFVVHwE130_assertion description "[These data support a role of E2F-1 as tumour suppressor gene in lymphoma and strongly suggest that the RB1 and p53 pathways are important in the development of de novo DLCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283301.RACm1-PxFfDdy1NHmFA-kI52NMIkY0F_VtfZqudFVVHwE130_provenance.
- NP283311.RAqGPmXROtOhX-wsQ4Y8L7e8Mhr8nLtGas1AvQUVy0SmA130_assertion description "[These data support a role of E2F-1 as tumour suppressor gene in lymphoma and strongly suggest that the RB1 and p53 pathways are important in the development of de novo DLCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283311.RAqGPmXROtOhX-wsQ4Y8L7e8Mhr8nLtGas1AvQUVy0SmA130_provenance.
- NP758946.RAJ5S5iqOrdbL-Qzc3yZC4xnFaDdSLedOxu9KJk5xLJ5Q130_assertion description "[These data support a role of E2F-1 as tumour suppressor gene in lymphoma and strongly suggest that the RB1 and p53 pathways are important in the development of de novo DLCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758946.RAJ5S5iqOrdbL-Qzc3yZC4xnFaDdSLedOxu9KJk5xLJ5Q130_provenance.
- NP283302.RA9JZsk_YdQn-_JSk08h15wnl6xZ5fuN_8KZV5aHHUhRs130_assertion description "[These data support a role of E2F-1 as tumour suppressor gene in lymphoma and strongly suggest that the RB1 and p53 pathways are important in the development of de novo DLCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283302.RA9JZsk_YdQn-_JSk08h15wnl6xZ5fuN_8KZV5aHHUhRs130_provenance.
- NP283303.RA61oDvkq17kKydoMWJ8aU-RwWq4mxtd9DctmvlcfFQ9Q130_assertion description "[These data support a role of E2F-1 as tumour suppressor gene in lymphoma and strongly suggest that the RB1 and p53 pathways are important in the development of de novo DLCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283303.RA61oDvkq17kKydoMWJ8aU-RwWq4mxtd9DctmvlcfFQ9Q130_provenance.